BIOSYM A/S: Financial statements 2023
CVR: 21774189
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOSYM A/S (CVR 21774189) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 15,335,405 and a net result of DKK 4,111,637 compared with DKK 2,110,000 the year before. That is an increase of 18% compared with the year before. Equity in the 2023 report amounted to DKK 33,970,374. The solvency ratio was 58.7%. The company had 18 employees in the financial year.
- Gross Profit
- DKK 15,335,405
- Profit/Loss
- DKK 4,111,637
- Equity
- DKK 33,970,374
- Total Assets
- DKK 57,825,792
- Employees
- 18
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 15.3 mio. | 4.1 mio. | 34 mio. | 18 |
| 2022 | - | 13 mio. | 2.1 mio. | 29.9 mio. | 18 |
| 2021 | - | 18.6 mio. | 7.1 mio. | 27.7 mio. | 18 |
| 2020 | - | 18 mio. | 6.7 mio. | 20.6 mio. | 19 |
| 2018 | - | 14.8 mio. | 6 mio. | 14.5 mio. | 19 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BIOSYM A/S has published its annual report for 2022. Gross profit came to DKK 12,990,839, and the net result was DKK 2,110,000.
About BIOSYM A/S
BIOSYM A/S is a Danish company of the type Aktieselskab based in Ikast, founded in 1999. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Sanne Biisgaard. The board consists of Kati Marika Rajala (chair), Elina Liisa Maarit Haavisto and Janne Vertanen. The company is owned by Oy Verman Ab. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK 23,552,721 and a net result of DKK 8,530,373 compared with DKK 3,810,817 the year before. Equity in the 2025 report amounted to DKK 46,311,564.